The Anesthesia Gases Market is estimated at US$1.95 billion in 2026 and is projected to grow at a CAGR of 3.7% to reach US$2.61 billion by 2034.
Its value chain includes gas producers, pharmaceutical manufacturers, distributors, hospitals, ambulatory centers, anesthesia providers, and equipment partners. Core applications include operating room anesthesia, procedural sedation, ambulatory surgery, pediatric care, hospital critical care support, and specialty intervention suites.
This product will be delivered within 1-3 business days.
Market Overview
The Anesthesia Gases Market covers medical gas products used to induce and maintain anesthesia in surgical and procedural settings across hospitals, ambulatory centers, and specialty clinics.Its value chain includes gas producers, pharmaceutical manufacturers, distributors, hospitals, ambulatory centers, anesthesia providers, and equipment partners. Core applications include operating room anesthesia, procedural sedation, ambulatory surgery, pediatric care, hospital critical care support, and specialty intervention suites.
Key Companies Analysed
- AbbVie
- Piramal Pharma
- Baxter
- Fresenius Kabi
- Linde
- Air Liquide
- Messer
- Praxair
- Nippon Gases
- Halocarbon
- B. Braun
- GE HealthCare
- Dräger
- Medtronic
- Mindray
- Nihon Kohden
- Becton Dickinson
- McKesson
- Cardinal Health
- BOC Healthcare
Geographic Coverage
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico
- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia
- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam
- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt
- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru
Report Delivery and Support
- Updated PDF report and an MS Excel workbook containing market tables and figures.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data.
- Complimentary report update covering the latest available data and relevant market developments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Contents and Report Guide
2. Global Anesthesia Gases Market Overview
3. Anesthesia Gases Market Dynamics
4. Anesthesia Gases Market Strategic Analysis
5. Global Anesthesia Gases Market Size, Share and Forecast, 2025-2034
6. North America Anesthesia Gases Market Outlook to 2034
7. Europe Anesthesia Gases Market Outlook to 2034
8. Asia-Pacific Anesthesia Gases Market Outlook to 2034
9. Middle East and Africa Anesthesia Gases Market Outlook to 2034
10. South and Central America Anesthesia Gases Market Outlook to 2034
11. Anesthesia Gases Market Competitive Landscape
12. Appendix
Companies Mentioned
- AbbVie
- Piramal Pharma
- Baxter
- Fresenius Kabi
- Linde
- Air Liquide
- Messer
- Praxair
- Nippon Gases
- Halocarbon
- B. Braun
- GE HealthCare
- Dräger
- Medtronic
- Mindray
- Nihon Kohden
- Becton Dickinson
- McKesson
- Cardinal Health
- BOC Healthcare
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 160 |
| Published | October 2026 |
| Forecast Period | 2026 - 2034 |
| Estimated Market Value ( USD | $ 1959 Million |
| Forecasted Market Value ( USD | $ 2619.8 Million |
| Compound Annual Growth Rate | 3.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 20 |
